Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsNeighborhood Health Plan RI OTC lidocaine Prior Au…
    Ask Trek AI about this page
    CurrentNeighborhood Health Plan of Rhode IslandPolicy N/A

    Coverage Criteria — High-cost over-the-counter lidocaine patches

    Customize your policy alerts

    Sign up for all Neighborhood Health Plan of Rhode Island policy alerts

    Know when Neighborhood Health Plan of Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Policy governs prior authorization and coverage criteria for high-cost over-the-counter (OTC) lidocaine patch preparations for Neighborhood Health Plan of Rhode Island members in the Medicaid portion of a FIDE SNP.

    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyCoverage Criteria — High-cost over-the-counter lidocaine patches
    Policy CodePolicy N/A
    Change TypeAdded cost-edit requiring prior authorization for >$200 fills
    Effective DateJan 1, 2026
    Last ReviewDec 1, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization with documentation of trial and failure of lower-cost formulary OTC lidocaine patch alternatives when a fill exceeds $200.
    SourceLink
    POLICY UPDATE CHANGES

    A maximum cost edit was implemented allowing OTC lidocaine patches under $200 per fill to adjudicate without authorization, while fills above $200 require prior authorization.

    $200maximum cost per fill allowed without prior authorization

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    $21.48
    average cost per fill (analysis)
    5xmax threshold vs average
    12 momaximum coverage duration

    Coverage Criteria

    Initial Therapy

    Authorization may be granted when ALL of the following are met:

    Initial Authorization - All criteria: A. The requested drug/product is being used per the product's labeling or for an FDA-approved or compendia/peer-reviewed medically accepted indication (AHFS-DI, Micromedex DrugDex, Clinical Pharmacology, Lexi-Drugs, or peer-reviewed literature).
    Initial Authorization - All criteria: B. The prescribed dose and quantity fall within the product's labeling or within FDA- or compendia-supported dosing guidelines.
    Initial Authorization - All criteria: C. Member has tried and failed all lower-cost formulary alternative over-the-counter lidocaine patch preparations; documentation of tried and failed alternatives must be submitted.

    Continuation Therapy

    Continuation may be approved when ALL of the following are met:

    Continuation Authorization: Patient meets all initial criteria in section I.

    Authorization for high-cost over-the-counter lidocaine patch preparations will be granted only when all clinical criteria in Section I are satisfied. These requirements include: the product is used per its labeling or for an FDA-approved or compendia/peer-reviewed medically accepted indication; the prescribed dose and quantity are within product labeling or FDA/compendia-supported dosing; and documentation that the member has tried and failed all lower-cost formulary OTC lidocaine patch alternatives. Requests exceeding the cost threshold (see Coding section) also require documentation of prior failures of lower-cost formulary alternatives to be considered for approval.

    Continuation of therapy may be approved when the patient meets all initial authorization criteria in Section I. Approvals for continuation should rely on the same documentation standards used at initiation, demonstrating ongoing use consistent with product labeling or compendia-supported indications and adherence to the previously approved dose and quantity.

    Initial Therapy

    Initial Therapy

    Initial authorization criteria for high-cost OTC lidocaine patches

    Initial: See Initial Authorization criteria: requested product used per labeling or for an FDA-approved or compendia/peer-reviewed medically accepted indication; prescribed dose and quantity within product labeling or FDA/compendia-supported dosing; member has tried and failed all lower-cost formulary alternative OTC lidocaine patch preparations with documentation submitted.

    Continuation Therapy

    Continuation

    Continuation of therapy requires ongoing adherence to initial criteria.

    Continuation: Patient continues to meet all initial criteria in section I (requested product used per labeling/medically accepted indication; dosing within labeling or compendia; documentation of prior failures of lower-cost formulary OTC lidocaine patches).

    Provider Actions & Prior Authorization

    Prior Authorization

    Prior authorization required for fills > $200

    Prior authorization is required for any over-the-counter lidocaine patch fill that exceeds $200 per fill; approval requires meeting the clinical criteria in Section I and submission of required documentation of prior failures of lower-cost formulary OTC lidocaine patches.

    Step Therapy

    Step requirement — trial of lower-cost formulary alternatives

    Member must have tried and failed all lower-cost formulary alternative OTC lidocaine patch preparations; documentation of those tried and failed alternatives must be submitted with the request.

    Documentation Required

    Coding & Cost Thresholds

    Maximum cost per fill
    Maximum cost per fill$200 per fill adjudicates without prior authorization; fills above $200 require prior authorization.
    Basis for thresholdImplemented to prevent Fraud, Waste & Abuse based on 2024–2025 utilization analysis where average cost per fill (excluding >$500 fills) was $21.48.
    Relative thresholdThreshold set to be at least 5 times the analyzed average fill amount.
    Effective applicationCost edit applies at pharmacy point-of-sale: requests >$200 will reject for the cost edit and require prior authorization.

    Step Therapy Requirements

    StepRequirementDocumentation Required
    1
    Member must have tried and failed all lower-cost formulary alternative OTC lidocaine patch preparations before approval of the requested high-cost product.
    Documentation of the tried and failed lower-cost formulary alternatives must be submitted with the request.

    Quantity Limits

    OTC lidocaine patch dosing
    Dosing standardDosing must follow the product's labeling or FDA/compendia-supported dosing guidelines.
    Permitted sourcesProduct labeling or recognized compendia (AHFS-DI, Micromedex DrugDex, Clinical Pharmacology, Lexi-Drugs) or peer-reviewed literature support dosing.
    Quantity limitsPrescribed dose and quantity must fall within the product's labeling or FDA/compendia-supported dosing guidelines.

    Definitions

    Medically accepted indication
    DefinitionUse supported by FDA labeling or recognized compendia (AHFS-DI, Micromedex DrugDex, Clinical Pharmacology, Lexi-Drugs) or peer-reviewed literature.
    Acceptable evidenceFDA-approved indications, product labeling, or evidence in standard reference compendia or peer-reviewed published medical literature.
    Application to authorizationRequested product must be used per labeling or for an FDA-approved or compendia/peer-reviewed medically accepted indication to meet approval criteria.

    Background

    Lidocaine topical patches are used for localized neuropathic pain and are available over-the-counter in multiple preparations and price points. To mitigate potential Fraud, Waste & Abuse, Neighborhood implemented a maximum cost edit effective for 2026 that permits OTC lidocaine patches costing under $200 per fill to adjudicate at the pharmacy without prior authorization. Fills above this threshold will reject for the cost edit and require prior authorization. The threshold was selected after a utilization review of August 2024–July 2025 claims, which showed an average cost per fill of $21.48 when very high-cost fills (> $500) were excluded, and was set to be at least 5× that analyzed average. Coverage duration for an approved authorization may be up to 12 months.

    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyCoverage Criteria — High-cost over-the-counter lidocaine patches
    Policy CodePolicy N/A
    Change TypeAdded cost-edit requiring prior authorization for >$200 fills
    Effective DateJan 1, 2026
    Last ReviewDec 1, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization with documentation of trial and failure of lower-cost formulary OTC lidocaine patch alternatives when a fill exceeds $200.
    SourceLink
    On This Page
    Coverage CriteriaInitial TherapyContinuation TherapyProvider Actions & Prior AuthorizationCoding & Cost ThresholdsStep Therapy RequirementsQuantity LimitsDefinitionsBackground

    Required documentation for prior authorization

    Documentation submitted for prior authorization must show use per product labeling or an FDA/compendia-supported medically accepted indication, that the prescribed dose and quantity fall within product labeling or compendia-supported dosing, and evidence that the member tried and failed all lower-cost formulary OTC lidocaine patch alternatives.

    • Support for indication from product labeling, FDA approval, or recognized compendia/peer-reviewed literature
    • Prescribed dose and quantity consistent with labeling or compendia dosing
    • Evidence of tried and failed lower-cost formulary OTC lidocaine patch alternatives
    Denial Risk

    Cost-edit rejection for fills > $200

    Requests for OTC lidocaine patch fills with a cost greater than $200 per fill will reject at the pharmacy for the cost edit and will require prior authorization before adjudication.